Dear Editor, Klebsiella pneumoniae is a Gram-negative bacterium that causes nosocomial infections such as septicaemia, pneumonia and urinary tract infection, especially in immunocompromised individuals. Recent studies show that antimicrobial drug resistance in K. pneumoniae has increased. [1] This emerging problem presents a major threat to public health and warrants due diligence in future surveillance efforts. There is an urgent need to investigate alterative treatment options while there are still a few antibiotics left. Bacteriophages are viruses that specifically target specific bacteria. [2] Many a time, there may be a need to eradicate specific bacteria from the gut. Therefore, it was hypothesised to see the effect of administration of oral bacteriophage on eradication of intestinal K. pneumoniae in Swiss albino mouse model. In our experimental study, two albino mice were subjected to single oral administration of specific bacteriophage with dosage of 1 ml/10 ml of water having lytic effect on the K. pneumoniae bacteria isolated from faeces of the same mouse mixed with water. Before administration of the bacteriophage, antimicrobial susceptibility was performed and it was found to be with multiple drug resistance, as seen in figure 1 . After administration, stool samples were collected and cultured to enumerate the colonies of K. pneumoniae. Isolation of the bacteriophage from the stool of the mice was performed naturally. It was found that there was gradual reduction of colony-forming unit of K. pneumoniae as the days progressed. Moreover, complete eradication was observed in 6 days of administration of bacteriophage. Initially, 32 colonies were observed and on the last day K. pneumoniae was completely eradication, as seen in figure 2 . Further, the same bacteriophage could be isolated from the faeces of mouse. The results indicate that bacteriophages are not killed by the acidity of stomach and targeted bacteria can be eradicated from the intestine.
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Oral Administration of Klebsiella pneumoniae-Specific Bacteriophage Eradicates the Bacteria in Albino Mice

High Prevalence of Varicella Seronegativity in Nurses at a Tertiary Care Private Hospital in Mumbai, India
Dear Editor, Varicella in healthcare workers (HCWs) is associated with morbidity, absenteeism and risk of transmission of disease to hospitalised patients. [1] Hence, immunisation of HCWs against varicella is a standard practice in the developed world. [1] In contrast, varicella immunisation in the Indian healthcare setup is not a routine practice. Studies on varicella immunogenicity report seronegativity in around 10%-15% of adults from India and other tropical Asian countries. [2] High seronegativity rates ranging from 25% to 70% have been reported in Indian HCWs. [3, 4] Kokilaben Dhirubhai Ambani Hospital is a 750-bedded tertiary-level hospital in Mumbai, India, commissioned in January 2009. In the end of 2011, 13 nurses residing in the nurse's hostel contracted chicken pox over a short span of 4 weeks. Hence, 2012 onwards, the hospital infection prevention and control committee started screening nurses with no history of chicken pox for anti-varicella immunoglobulin G (IgG). A total of 600 nurses were interviewed, of which 247 nurses were tested; 120 were seronegative and offered the vaccine. Despite this strategy, both outbreaks and sporadic cases continued to occur. Hence, 2014 onwards, it was decided to test all nurses irrespective of a history of chicken pox for anti-varicella IgG.
Since the past 4 years (2014-2017), a total of 5000 nurses have been tested with anti-varicella IgG ELISA (Novatech, Germany), of which 1400 were seronegative (28%). Most of these nurses were in the age bracket of 21-30 years. Vaccination with two doses of the vaccine was offered to all seronegative nurses. Since then, a significant decline in chicken pox cases in nurses has been observed.
Our study highlights the need for varicella immunisation of Indian HCWs. The World Health Organization recommends that even those countries where varicella vaccine is not included in the usual immunisation schedule should consider vaccinating its susceptible HCWs against varicella, especially those in contact with immunocompromised and premature infants. [5] The recommended schedule is two doses of the varicella vaccine (0.5 ml) administered subcutaneously 4-8 weeks apart. However, the high cost of anti-varicella IgG/vaccine and rapid attrition of nursing staff are logistic problems that need attention.
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